InspireMD, Inc.
NSPR
$0.76
-$0.01-1.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.85M | 8.98M | 7.78M | 7.07M | 7.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.85M | 8.98M | 7.78M | 7.07M | 7.03M |
| Cost of Revenue | 7.80M | 6.33M | 5.84M | 5.58M | 5.52M |
| Gross Profit | 3.04M | 2.65M | 1.94M | 1.49M | 1.51M |
| SG&A Expenses | 39.47M | 37.26M | 33.61M | 28.30M | 23.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.98M | 58.59M | 54.68M | 49.37M | 44.58M |
| Operating Income | -52.13M | -49.61M | -46.90M | -42.31M | -37.55M |
| Income Before Tax | -51.25M | -48.72M | -46.14M | -41.32M | -36.08M |
| Income Tax Expenses | 63.00K | 63.00K | 59.00K | 59.00K | 59.00K |
| Earnings from Continuing Operations | -51.31 | -48.79 | -46.20 | -41.38 | -36.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.31M | -48.79M | -46.20M | -41.38M | -36.14M |
| EBIT | -52.13M | -49.61M | -46.90M | -42.31M | -37.55M |
| EBITDA | -51.61M | -49.14M | -46.49M | -41.96M | -37.24M |
| EPS Basic | -0.74 | -0.80 | -0.84 | -0.83 | -0.79 |
| Normalized Basic EPS | -0.46 | -0.50 | -0.53 | -0.52 | -0.50 |
| EPS Diluted | -0.74 | -0.80 | -0.84 | -0.83 | -0.79 |
| Normalized Diluted EPS | -0.46 | -0.50 | -0.53 | -0.52 | -0.50 |
| Average Basic Shares Outstanding | 290.64M | 256.83M | 223.35M | 198.26M | 183.13M |
| Average Diluted Shares Outstanding | 290.64M | 256.83M | 223.35M | 198.26M | 183.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |